A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
Wen Wee MaJenny J LiNilofer S AzadElaine T LamJennifer R DiamondGrace K DyMateusz OpyrchalJay ZhiDouglas KramerWing-Kai ChanDavid CutlerRudolf KwanAlex A AdjeiAntonio JimenoPublished in: Cancer chemotherapy and pharmacology (2022)
The oral administration of encequidar with paclitaxel was safe, achieved clinically relevant paclitaxel levels, and showed evidence of anti-tumor activity.
Keyphrases